StockData
Oric Pharmaceuticals, Inc. logo

Oric Pharmaceuticals, Inc. (ORIC) income statement

ORICNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 8/30
$7.36−0.34 (-4.42%)

Close on Nov 20, 2026Market cap $762.88MP/E –Yield –

See a number that looks wrong?